Raphael J. Mannino

Filings by Raphael J. Mannino span 2 companies, the busiest being Matinas BioPharma Holdings, Inc. and Biodelivery Sciences International Inc. We count 10 filings; the first trade dates from 6 June 2007 and the latest from 3 September 2021.

Both buying and selling appear: 1 purchase worth €5,895, against 2 sales worth €74k. Netting one side against the other leaves €68k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 option exercises.

The latest filing, published on 14 September 2021, reports a transaction in Matinas BioPharma Holdings, Inc. The last insider purchase was made public on 15 September 2017, 3,325 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.